2002
DOI: 10.1577/1548-8454(2002)064<0122:bcotpc>2.0.co;2
|View full text |Cite
|
Sign up to set email alerts
|

Biological Control of the Parasitic CopepodSalmincola californiensisin a Commercial Trout Hatchery on the Lower Merced River, California

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…primarily attach to the gills, opercula, and mouth cavity of fish (Kabata and Cousens 1973), often resulting in severe gill damage and respiratory stress (Sutherland and Wittrock 1985;Mitchum 1995;Duston and Cusack 2002;Roberts et al 2004). The control methods tested to date have had limited success (Johnson and Heindel 2001;Duston and Cusack 2002;Modin and Veek 2002;Roberts et al 2004;Lester and Hayward 2006), and no chemotherapeutic treatments have been approved for use in the United States. SLICE (0.2% emamectin benzoate [EB]) is an in-feed treatment developed by Intervet/Schering-Plough (now Merck) Animal Health (Roseland, New Jersey) to control infestations of ectoparasitic crustacean sea lice (e.g., Lepeophtheirus salmonis and Caligus elongatus) in seawater-reared Atlantic salmon Salmo salar (Stone et al 1999(Stone et al , 2000b(Stone et al , 2000cISPAH 2003).…”
mentioning
confidence: 99%
“…primarily attach to the gills, opercula, and mouth cavity of fish (Kabata and Cousens 1973), often resulting in severe gill damage and respiratory stress (Sutherland and Wittrock 1985;Mitchum 1995;Duston and Cusack 2002;Roberts et al 2004). The control methods tested to date have had limited success (Johnson and Heindel 2001;Duston and Cusack 2002;Modin and Veek 2002;Roberts et al 2004;Lester and Hayward 2006), and no chemotherapeutic treatments have been approved for use in the United States. SLICE (0.2% emamectin benzoate [EB]) is an in-feed treatment developed by Intervet/Schering-Plough (now Merck) Animal Health (Roseland, New Jersey) to control infestations of ectoparasitic crustacean sea lice (e.g., Lepeophtheirus salmonis and Caligus elongatus) in seawater-reared Atlantic salmon Salmo salar (Stone et al 1999(Stone et al , 2000b(Stone et al , 2000cISPAH 2003).…”
mentioning
confidence: 99%
“…These large-scale production facilities are operated by state and federal agencies to stock large areas for public recreational fishing. One problem with this type of facility is that animals in the source water are often carriers of serious diseases that are easily spread to other fish (Kowalski and Bergersen 2003;Mitchell 2002;Modin and Veek 2002). The concrete tanks are also costly to install, are not easily modified or moved, and time consuming to clean; in addition, the concrete erodes the soft fins of the fish.…”
Section: Current Trendsmentioning
confidence: 99%
“…A host of S. californiensis, rainbow trout Oncorhynchus mykiss (Walbaum 1792), is arguably one of the most widely stocked sport fish in the world, historically stocked in over 80 countries on six continents (Halverson 2010), and gill lice have been spread through stocking, moving water and other anthropogenic activities associated with fish introductions (Sutherland & Whittrock 1985). The negative effects of S. californiensis threaten native fish and hatchery stocks of fish (Modin & Veek 2011;Gunn et al 2012;Hargis et al 2014). Improved understanding of this species' life history may provide insight into managing popular sport fish and native salmonids in the presence of gill lice.…”
Section: Introductionmentioning
confidence: 99%